Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

J Mol Biol. 2022 Mar 15;434(5):167420. doi: 10.1016/j.jmb.2021.167420. Epub 2021 Dec 23.

Abstract

Phages, plasmids, and other mobile genetic elements express inhibitors of CRISPR-Cas immune systems, known as anti-CRISPR proteins, to protect themselves from targeted destruction. These anti-CRISPR proteins have been shown to function through very diverse mechanisms. In this work we investigate the activity of an anti-CRISPR isolated from a prophage in Haemophilus parainfluenzae that blocks CRISPR-Cas9 DNA cleavage activity. We determine the three-dimensional crystal structure of AcrIIC4Hpa and show that it binds to the Cas9 Recognition Domain. This binding does not prevent the Cas9-anti-CRISPR complex from interacting with target DNA but does inhibit DNA cleavage. AcrIIC4Hpa likely acts by blocking the conformational changes that allow the HNH and RuvC endonuclease domains to contact the DNA sites to be nicked.

Keywords: CRISPR-Cas; Cas9; anti-CRISPR; inhibition; mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteriophages* / enzymology
  • CRISPR-Associated Protein 9* / antagonists & inhibitors
  • CRISPR-Associated Protein 9* / chemistry
  • DNA Cleavage*
  • Haemophilus parainfluenzae* / virology
  • Prophages / enzymology
  • Protein Domains
  • Viral Proteins* / chemistry
  • Viral Proteins* / metabolism

Substances

  • Viral Proteins
  • CRISPR-Associated Protein 9

Grants and funding